Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Weeks, Jenni N; Boyd, Kelli L; Rajam, Gowrisankar; Ades, Edwin W; McCullers, Jonathan A

Weeks, Jenni N; Boyd, Kelli L; Rajam, Gowrisankar; Ades, Edwin W; McCullers, Jonathan A.

Affiliation

Weeks JN; Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

Antimicrob Agents Chemother ; 55(5): 2276-81, 2011 May.

Article in En | MEDLINE | ID: mdl-21383090

Subject(s)

Immunoglobulins, Intravenous/therapeutic use; Pneumonia, Pneumococcal/drug therapy; Animals; Female; Immunotherapy; Mice; Mice, Inbred BALB C; Pneumonia, Pneumococcal/microbiology; Streptococcus pneumoniae/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumonia, Pneumococcal / Immunoglobulins, Intravenous Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google